Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration

Overview of attention for article published in Graefe's Archive for Clinical and Experimental Ophthalmology, August 2009

Altmetric Badge

Mentioned by

policy: 1 policy source

Readers on

mendeley: 50 Mendeley
citeulike: 1 CiteULike

Summary Policy documents

So far, Altmetric has seen 2 policy documents that reference this research output.

Age-related macular degeneration : Appendix F: Excluded studies

Cited by National Institute for Health and Care Excellence on 16 Jan 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Aflibercept solution for injection for treating wet age‑related macular degeneration: Macular degeneration (wet age-related) - aflibercept (1st line): evaluation report

Cited by National Institute for Health and Care Excellence on 11 Jul 2013

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.